BELLICUM PHARMACEUTICALS, INC. BLCM Balance Sheet

Bellicum pharmaceuticals, inc. (BLCM)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14
ASSETS
Current assets:
Cash and cash equivalents
74,555	91,028	99,151	-	-	43,695	-	-	-	38,839	-	-	-	33,140	-	-	-	70,241	-	-	-	-
Restricted cash, current
939	2,788	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment securities, available for sale
-	-	-	-	-	49,304	-	-	-	60,057	-	-	-	-	-	-	-	-	-	-	-	-
Cash and cash equivalents
-	-	-	42,857	42,274	-	53,027	73,458	31,794	-	54,468	75,148	96,640	-	48,694	49,549	61,790	-	92,487	101,646	183,638	191,602
Investment securities, available for sale - short-term
-	-	4,152	13,709	31,210	-	59,720	55,923	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment securities, available for sale - short-term
-	-	-	-	-	-	-	-	50,313	-	58,608	55,081	50,924	70,632	56,613	56,025	46,482	23,820	20,744	17,649	-	0
Accounts receivable, interest and other receivables
46	303	328	537	947	909	538	344	421	320	468	275	284	334	305	382	-	440	-	-	-	298
Accounts receivable, interest and other receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	361	-	388	462	94	-
Prepaid expenses and other current assets
1,633	884	1,234	2,001	2,254	1,387	2,254	2,545	2,407	2,434	2,114	2,621	2,449	1,504	1,975	2,223	2,268	2,389	1,702	2,182	1,279	1,322
Assets held for sale
17,050	16,851	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets
94,223	111,854	104,865	59,104	76,685	95,295	115,539	132,270	84,935	101,650	115,658	133,125	150,297	105,610	107,587	108,179	110,901	96,890	115,321	121,939	185,011	193,222
Operating lease right-of-use assets
957	1,042	6,234	5,589	4,655	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment securities, available for sale - long-term
-	-	-	-	-	-	0	0	0	1,368	2,556	4,405	9,702	0	23,791	30,999	43,536	56,304	50,018	53,270	-	0
Property and equipment, net
1,830	2,529	16,204	17,870	19,189	20,878	22,402	23,854	25,152	25,942	26,252	25,458	21,031	16,504	11,064	10,512	8,731	6,882	6,323	4,798	3,164	2,427
Restricted cash, noncurrent
-	-	3,600	4,000	4,585	4,973	5,635	5,902	5,931	6,190	2,947	4,383	7,371	9,640	-	-	-	0	-	-	-	-
Other assets
511	825	3,026	3,158	3,054	355	396	396	334	378	358	353	358	283	262	240	346	330	446	230	97	145
Total assets
97,521	116,250	133,932	89,705	108,168	121,501	143,972	162,422	116,352	135,528	147,771	167,724	188,759	132,037	142,704	149,930	163,514	160,406	172,108	180,237	188,272	195,794
LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable
1,794	2,643	1,300	2,039	2,027	3,774	1,843	1,482	2,016	3,287	3,162	2,103	2,527	3,623	1,618	980	1,774	2,106	1,534	814	1,115	1,209
Accrued expenses and other current liabilities
8,075	9,770	14,363	12,560	10,389	8,589	8,837	7,417	6,952	6,392	8,550	10,164	10,569	9,363	6,796	5,367	5,369	5,080	3,315	1,754	1,079	2,163
Warrant derivative liability
15,265	52,184	37,842	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Private placement option liability
16,187	12,094	12,094	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of long-term debt
11,195	11,000	8,000	5,000	-	0	-	-	-	-	6,913	3,412	0	1,787	-	-	-	0	-	-	-	-
Current portion of lease liabilities
472	454	1,866	-	-	40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of lease liabilities
-	-	-	1,432	1,282	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of capital lease obligations
-	-	-	-	-	-	37	35	33	31	29	27	23	21	19	18	15	13	-	-	-	0
Current portion of deferred revenue
-	-	973	1,075	2,467	2,983	3,295	-	-	2,049	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of deferred revenue
-	-	-	-	-	-	-	3,587	3,194	-	-	-	-	0	-	-	-	-	0	0	0	13
Current portion of deferred rent
-	-	0	0	0	418	411	407	402	397	359	256	364	319	246	246	246	246	170	30	26	97
Liabilities Held-For-Sale, Not Part Of Disposal Group, Current
5,921	6,273	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of deferred manufacturing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	376	428	154
Total current liabilities
58,909	94,418	76,438	22,106	16,165	15,804	14,423	12,928	12,597	12,156	19,013	15,962	13,483	15,113	8,679	6,611	7,404	7,445	5,019	2,974	2,648	3,636
Long-term liabilities:
Long-term debt, net of deferred issuance costs
23,736	25,717	-	-	-	35,832	-	-	-	34,946	-	-	-	18,436	-	-	-	-	-	-	-	-
Long-term debt, net of deferred financing costs
-	-	28,494	31,271	36,050	-	35,609	35,388	35,165	-	23,839	27,116	30,312	-	20,076	14,951	14,829	0	-	-	-	-
Long-term lease liabilities
739	864	6,163	-	-	91	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term lease liabilities
-	-	-	6,020	5,093	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital lease obligations
-	-	-	-	-	-	102	112	122	131	140	148	135	141	136	140	132	118	-	-	-	0
Deferred revenue
-	-	-	-	-	-	0	-	-	2,054	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	0	755	-	-	-	-	0	-	-	-	-	-	-	-	-
Deferred rent
-	-	0	0	0	1,296	1,381	1,456	1,530	1,593	1,662	1,791	1,705	1,773	726	741	783	826	984	254	263	209
Deferred manufacturing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	313
Total long-term liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	984	254	263	-
Total liabilities
83,384	120,999	111,095	59,397	57,308	53,023	51,515	49,884	50,169	50,880	44,654	45,017	45,635	35,463	29,617	22,443	23,148	8,389	6,003	3,228	2,911	4,158
Commitments and contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	0	0	0	0	-
Preferred stock: $0.01 par value; 10,000,000 shares authorized
21,308	21,468	21,608	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stockholders’ deficit:
Preferred stock: $0.01 par value; 10,000,000 shares authorized: no shares issued and outstanding
-	-	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-
Common stock, $0.01 par value; 40,000,000 shares authorized at March 31, 2020 and December 31, 2019, 5,117,638 shares issued and 5,049,892 shares outstanding at March 31, 2020; 5,076,593 shares issued and 5,008,846 shares outstanding at December 31, 2019
51	507	503	469	456	442	440	440	343	340	339	339	338	278	278	277	277	276	272	271	271	271
Treasury stock: 67,746 shares held at March 31, 2020 and December 31, 2019
5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056	5,056
Additional paid-in capital
513,623	511,684	509,963	507,013	500,601	493,784	490,436	486,749	416,352	411,922	408,412	404,593	400,538	332,068	328,582	325,246	321,768	318,591	315,736	313,234	310,848	309,365
Accumulated other comprehensive loss
-340	-327	-137	-106	-65	-144	-35	-68	-104	-46	16	-6	10	17	78	96	-56	-302	-204	-204	-120,702	0
Accumulated deficit
-515,400	-533,000	-504,044	-472,000	-445,076	-420,548	-393,328	-369,527	-345,352	-322,512	-300,594	-277,163	-252,706	-230,733	-210,795	-193,076	-176,567	-161,492	-144,643	-131,236	-	-112,944
Total stockholders’ deficit
-7,171	-26,217	1,229	30,308	50,860	68,478	92,457	112,538	66,183	84,648	103,117	122,707	143,124	96,574	113,087	127,487	140,366	152,017	166,105	177,009	185,361	191,636
Total liabilities, preferred stock and stockholders' deficit
97,521	116,250	133,932	89,705	108,168	121,501	143,972	162,422	116,352	135,528	147,771	167,724	188,759	132,037	142,704	149,930	163,514	160,406	172,108	180,237	188,272	195,794
Series 1 Preferred Stock
Preferred stock: $0.01 par value; 10,000,000 shares authorized
-	-	21,608	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-